2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 热门AI工具： |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF CLINICAL ONCOLOGY J CLIN ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.9
53人评分
我要评分
声誉 9.9 影响力 9.9 速度 9.1 | |||||||||||||||||||||
| 期刊ISSN | 0732-183X | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1527-7755 | |||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年9月20日：30.85 | |||||||||||||||||||||
| 2025-2026自引率 | 1.6%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 41.302数据由网友[等待runner]收集提供 | |||||||||||||||||||||
| h-index | 494 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://jco.ascopubs.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/JCO-ASCOPUBS | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection Author: Shi, Haoting; Huang, Jiahui; Chen, Xiaosong; Shen, Kunwei Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 24, pp. 2357-2358. DOI: 10.1200/JCO-26-00605 Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study Author: Burtness, Barbara; Rosenberg, Ari J.; Calderon, Benoit; Lim, Sun Min; Yang, Muh-Hwa; Li, Shau-Hsuan; Kadowaki, Shigenori; Swiecicki, Paul L.; Geiger, Jessica L.; Ince, William; Hahn, Dennis; Guo, Ye; Adkins, Douglas; Metcalf, Robert; Ahn, Myung-Ju; Sukari, Ammar; Brana, Irene; Keam, Bhumsuk; Tanaka, Hideki; Sheth, Siddharth; Oliva, Marc; Lyu, Xuesong; Curtin, Joshua C.; Toyoizumi, Kiichiro; Xie, John; Wade, Mark; Diorio, Brooke; Kapoor, Aastha; Yilmaz, Emrullah; Baig, Mahadi; Kim, Priya; Verheijen, Remy B.; Shah, Sujay; Harrington, Kevin J.; Abdeddaim, Cyril; Bhatia, Aarti; Forster, Martin; Geiger, Jessica; Haigentz, Missak; Harrington, Kevin; Iglesias, Lara; Ji, Dongmei; Kawecki, Andrzej; Kerrigan, Kathleen; Kim, Sung-Bae; Lin, Jin-Ching; Liu, Lei; McDermott, Jessica; Pawlowska, Ewa; Rosenberg, Ari; Rutkowski, Tomasz; Sandhu, Malwinder; Shariff, Nisha Mohd; Spira, Alexander; Swiecicki, Paul Loren; Viala, Caroline; Vidales, Zara; Wang, Hung-Ming; Yang, Kunyu Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 24, pp. 2271-2277. DOI: 10.1200/JCO-26-01042 RETRACTION: Randomized Trial of Relevance of Time-of-Day of Immunochemotherapy for Progression-free and Overall Survival in Patients With Non-small Cell Lung Cancer Author: Zhang, Yongchang; Huang, Zhe; Zeng, Liang; Ruan, Zhaohui; Zeng, Qun; Yan, Huan; Jiang, Wenjuan; Dai, Jiacheng; Zou, Nachuan; Xu, Shidong; Deng, Jun; Chen, Xue; Wang, Jing; Xiang, Hua; Li, Xiaomei; Duchemann, Boris; Chen, Guoqiang; Scheiermann, Christoph; Yang, Nong; Levi, Francis Albert Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 23, pp. e125-e125. DOI: 10.1200/JCO-26-01619 EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer Author: Nakayama, Izuma; Ryu, Min-Hee; Lim, Sung Hee; Kim, Jong Gwang; Omori, Takeshi; Oh, Sang Cheul; Kim, Jin Young; Rha, Sun Young; Lee, Keun-Wook; Machida, Nozomu; Sym, Sun Jin; Narita, Yukiya; Park, Young-Iee; Hara, Hiroki; Hosaka, Hisashi; Kang, Beodeul; Kim, In-Ho; Bai, Li-Yuan; Hirashima, Yoshinori; Hagihara, Shunsuke; Yamamoto, Takanori; Shitara, Kohei Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 23, pp. 2198-2210. DOI: 10.1200/JCO-26-01072 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JOURNAL OF CLINICAL ONCOLOGY的语言要求，还能让JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | AMER SOC CLINICAL ONCOLOGY, 2318 MILL ROAD, STE 800, ALEXANDRIA, USA, VA, 22314 | |||||||||||||||||||||
| 出版商 | American Society of Clinical Oncology | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Biweekly | |||||||||||||||||||||
| 出版年份 | 1983 | |||||||||||||||||||||
| 年文章数 | 308点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 36.39% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 97.08% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | 注册或登录后，查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0732-183X%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约20% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JOURNAL OF CLINICAL ONCOLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection Author: Shi, Haoting; Huang, Jiahui; Chen, Xiaosong; Shen, Kunwei Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 24, pp. 2357-2358. DOI: 10.1200/JCO-26-00605 PubMed DOI |
| 2. | Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study Author: Burtness, Barbara; Rosenberg, Ari J.; Calderon, Benoit; Lim, Sun Min; Yang, Muh-Hwa; Li, Shau-Hsuan; Kadowaki, Shigenori; Swiecicki, Paul L.; Geiger, Jessica L.; Ince, William; Hahn, Dennis; Guo, Ye; Adkins, Douglas; Metcalf, Robert; Ahn, Myung-Ju; Sukari, Ammar; Brana, Irene; Keam, Bhumsuk; Tanaka, Hideki; Sheth, Siddharth; Oliva, Marc; Lyu, Xuesong; Curtin, Joshua C.; Toyoizumi, Kiichiro; Xie, John; Wade, Mark; Diorio, Brooke; Kapoor, Aastha; Yilmaz, Emrullah; Baig, Mahadi; Kim, Priya; Verheijen, Remy B.; Shah, Sujay; Harrington, Kevin J.; Abdeddaim, Cyril; Bhatia, Aarti; Forster, Martin; Geiger, Jessica; Haigentz, Missak; Harrington, Kevin; Iglesias, Lara; Ji, Dongmei; Kawecki, Andrzej; Kerrigan, Kathleen; Kim, Sung-Bae; Lin, Jin-Ching; Liu, Lei; McDermott, Jessica; Pawlowska, Ewa; Rosenberg, Ari; Rutkowski, Tomasz; Sandhu, Malwinder; Shariff, Nisha Mohd; Spira, Alexander; Swiecicki, Paul Loren; Viala, Caroline; Vidales, Zara; Wang, Hung-Ming; Yang, Kunyu Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 24, pp. 2271-2277. DOI: 10.1200/JCO-26-01042 PubMed DOI |
| 3. | RETRACTION: Randomized Trial of Relevance of Time-of-Day of Immunochemotherapy for Progression-free and Overall Survival in Patients With Non-small Cell Lung Cancer Author: Zhang, Yongchang; Huang, Zhe; Zeng, Liang; Ruan, Zhaohui; Zeng, Qun; Yan, Huan; Jiang, Wenjuan; Dai, Jiacheng; Zou, Nachuan; Xu, Shidong; Deng, Jun; Chen, Xue; Wang, Jing; Xiang, Hua; Li, Xiaomei; Duchemann, Boris; Chen, Guoqiang; Scheiermann, Christoph; Yang, Nong; Levi, Francis Albert Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 23, pp. e125-e125. DOI: 10.1200/JCO-26-01619 PubMed DOI |
| 4. | EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer Author: Nakayama, Izuma; Ryu, Min-Hee; Lim, Sung Hee; Kim, Jong Gwang; Omori, Takeshi; Oh, Sang Cheul; Kim, Jin Young; Rha, Sun Young; Lee, Keun-Wook; Machida, Nozomu; Sym, Sun Jin; Narita, Yukiya; Park, Young-Iee; Hara, Hiroki; Hosaka, Hisashi; Kang, Beodeul; Kim, In-Ho; Bai, Li-Yuan; Hirashima, Yoshinori; Hagihara, Shunsuke; Yamamoto, Takanori; Shitara, Kohei Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 23, pp. 2198-2210. DOI: 10.1200/JCO-26-01072 PubMed DOI |
| 5. | RETRACTION: Neoadjuvant Adebrelimab Plus Chemotherapy in Untreated Locally Advanced Head and Neck Squamous Cell Carcinoma: Efficacy and Biomarker Insights From a Single-Arm Phase II Trial Author: Fang, Ruihua; Lei, WenBin; Huang, Bixue; Chen, Lin; Zhan, Rongjian; Wen, Weiping; Luo, Jierong Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 23, pp. e126-e126. DOI: 10.1200/JCO-26-01525 PubMed DOI |
| 6. | Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor Author: Eyre, Toby A.; Song, Yuqin; Hermine, Olivier; Shuang, Yuerong; Jurczak, Wojciech; Farias, Joao Samuel; Mahuad, Carolina; Ozcan, Muhit; Jachimowicz, Ron D.; Chen, Tianlei; Ivanova, Elena; Li, Xiaotong; Man, Gabriel; Bourquelot, Priscille; Vezan, Remus; Wang, Michael Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 23, pp. 2233-2243. DOI: 10.1200/JCO-26-00550 PubMed DOI |
| 7. | Multicenter Cohort Study of Original or Substitute Systemic Therapy With or Without Brain Radiotherapy for Extensive-Stage Small Cell Lung Cancer With Brain-Only Progression After First-Line Treatment Author: Lu, Shuangqing; Jia, Jingyi; Ren, Kai; Jia, Wenxiao; Sun, Zhuoran; Zhao, Ke; Cai, Xuwei; Zhao, Lujun; Zhu, Hui Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 22, pp. 2087-2097. DOI: 10.1200/JCO-25-02536 PubMed DOI |
| 8. | Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer Author: Qi, Changsong; Liu, Chang; Gong, Jifang; Wang, Xicheng; Wang, Zhenghang; Xu, Ting; Liu, Dan; Zhang, Panpan; Li, Jiarui; Zhang, Miao; Zhang, Xiaotian; Lu, Ming; Zhou, Jun; Lu, Zhihao; Peng, Zhi; Cao, Yanshuo; Yuan, Jiajia; Wang, Yakun; Lu, Xin'an; He, Ting; Ding, Yanping; Wu, Fei; Liu, Dongqun; Li, Jian; Shen, Lin Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 21, pp. 2006-2016. DOI: 10.1200/JCO-25-01090 PubMed DOI |
| 9. | In DeFi-ance of More Is Better: Questioning Long-Term Nirogacestat Use in Desmoid Tumors Author: Dossa, Fahima; Raut, Chandrajit P.; Wagner, Andrew J.; Jones, Robin L.; Gladdy, Rebecca A.; Gupta, Abha A.; Cardona, Kenneth; Gyorki, David E.; Chen, Tom W.; Loong, Herbert H.; Bonvalot, Sylvie; Stacchiotti, Silvia; Gronchi, Alessandro Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 21, pp. 2062-2063. DOI: 10.1200/JCO-25-02927 PubMed DOI |
| 10. | Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology Author: Xu, Jian; Wu, Guo; Li, Jingdong Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 20, pp. 1947-1949. DOI: 10.1200/JCO-25-01989 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共117条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
